rs12863734
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032229.3(SLITRK6):c.73C>T(p.Leu25Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.016 in 1,608,624 control chromosomes in the GnomAD database, including 225 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_032229.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLITRK6 | NM_032229.3 | c.73C>T | p.Leu25Phe | missense_variant | 2/2 | ENST00000647374.2 | NP_115605.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLITRK6 | ENST00000647374.2 | c.73C>T | p.Leu25Phe | missense_variant | 2/2 | NM_032229.3 | ENSP00000495507.1 | |||
SLITRK6 | ENST00000643778.1 | c.73C>T | p.Leu25Phe | missense_variant | 3/3 | ENSP00000496428.1 | ||||
SLITRK6 | ENST00000645642.1 | n.521-493C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0182 AC: 2761AN: 151826Hom.: 27 Cov.: 32
GnomAD3 exomes AF: 0.0154 AC: 3746AN: 243532Hom.: 46 AF XY: 0.0144 AC XY: 1907AN XY: 132162
GnomAD4 exome AF: 0.0157 AC: 22938AN: 1456680Hom.: 197 Cov.: 35 AF XY: 0.0151 AC XY: 10945AN XY: 724612
GnomAD4 genome AF: 0.0182 AC: 2772AN: 151944Hom.: 28 Cov.: 32 AF XY: 0.0184 AC XY: 1369AN XY: 74286
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 12, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Leu25Phe in exon 2 of SLITRK6: This variant is not expected to have clinical s ignificance because it has been identified in 2.59% (294/11348) of Latino chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs12863734). - |
SLITRK6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at